StockMarketWire.com - Jane Kingston, Non Executive Director, bought 1,080 shares in the company on the 16th March 2017 at a price of 4786.54p. The Director now holds 1,080 shares representing 0.00% of the shares in issue.
The stock and a handful of other winners account for the bulk of the S&P 500’s SPX gains this year. The ascent has made Facebook one of the ten largest S&P companies in terms of market capitalization, with the stock now worth more than …
Major world stock markets rose and government bond yields fell on Tuesday as a combination of strong corporate profits, steady global growth and low inflation provide scant alternatives for investors other than equities. Stocks markets from …
Target (TGT) stock is up about 12.3% on a YTD (year-to-date) basis as of February 7, 2018, and has outperformed its peers. Plus, the company has also exceeded the S&P 500 Index (SPX-INDEX) in terms of price appreciation, as the …
SmarTrend identified an Uptrend for Spx Flow Inc (NYSE:FLOW) on September 5th, 2017 at $34.22. In approximately 4 months, Spx Flow Inc has returned 39.59% as of today's recent price of $47.76. Over the past year, Spx Flow Inc has …
Goldsboro, N.C. — Two workers died and a third was injured Monday after an industrial accident at the SPX Transformer Solutions Inc. plant in Wayne County. Authorities said that emergency personnel were called to the Goldsboro plant at …
Has billionaire investor George Soros had a change of heart on the S&P 500? Fast-forward to the third quarter, and it appears Soros\’s fund has cut that S&P 500 bearish call by two-thirds, reducing the value of the holding to around $470 …
SPX FLOW, Inc. is a global supplier of engineered solutions. As of December 31, 2016, the Company had operations in over 30 countries and sales in over 150 countries around the world. The Company operates in three business …
Teva registered a 13% drop as trade opened at the Tel Aviv stock exchange Sunday. The drop in the pharmaceutical company's stocks comes after the FDA approved a generic version of Teva's flagship medicine Copaxone, used for …